70 related articles for article (PubMed ID: 23095426)
1. Management strategies for attention-deficit/hyperactivity disorder: a regional deliberation on the evidence.
Emond SK; Ollendorf DA; Colby JA; Reed SJ; Pearson SD
Postgrad Med; 2012 Sep; 124(5):58-68. PubMed ID: 23095426
[TBL] [Abstract][Full Text] [Related]
2. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
Foy JM; Earls MF
Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
[TBL] [Abstract][Full Text] [Related]
3. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.
Brown RT; Amler RW; Freeman WS; Perrin JM; Stein MT; Feldman HM; Pierce K; Wolraich ML; ;
Pediatrics; 2005 Jun; 115(6):e749-57. PubMed ID: 15930203
[TBL] [Abstract][Full Text] [Related]
4. [Better health care for children and adolescents with attention deficit hyperactivity disorder].
Klasen H; Verhulst FC
Ned Tijdschr Geneeskd; 2005 Jul; 149(31):1723-5. PubMed ID: 16114286
[TBL] [Abstract][Full Text] [Related]
5. A randomized, controlled effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methylphenidate in attention deficit-hyperactivity disorder.
Steele M; Weiss M; Swanson J; Wang J; Prinzo RS; Binder CE
Can J Clin Pharmacol; 2006; 13(1):e50-62. PubMed ID: 16456216
[TBL] [Abstract][Full Text] [Related]
6. Children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment: impact on parental practices.
Hechtman L; Abikoff H; Klein RG; Greenfield B; Etcovitch J; Cousins L; Fleiss K; Weiss M; Pollack S
J Am Acad Child Adolesc Psychiatry; 2004 Jul; 43(7):830-8. PubMed ID: 15213584
[TBL] [Abstract][Full Text] [Related]
7. Management options for children with attention-deficit/hyperactivity disorder: a regional perspective on value.
Ollendorf DA; Migliaccio-Walle K; Colby JA; Pearson SD
J Comp Eff Res; 2013 May; 2(3):261-71. PubMed ID: 24236625
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).
NIH Consens Statement; 1998 Nov 16-18; 16(2):1-37. PubMed ID: 10868163
[TBL] [Abstract][Full Text] [Related]
9. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
Chou WJ; Chou MC; Tzang RF; Hsu YC; Gau SS; Chen SJ; Wu YY; Huang YF; Liang HY; Cheng H
Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
[TBL] [Abstract][Full Text] [Related]
10. Parental angst making and revisiting decisions about treatment of attention-deficit/hyperactivity disorder.
Brinkman WB; Sherman SN; Zmitrovich AR; Visscher MO; Crosby LE; Phelan KJ; Donovan EF
Pediatrics; 2009 Aug; 124(2):580-9. PubMed ID: 19651580
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of theophylline compared to methylphenidate for the treatment of attention-deficit hyperactivity disorder in children and adolescents: a pilot double-blind randomized trial.
Mohammadi MR; Kashani L; Akhondzadeh S; Izadian ES; Ohadinia S
J Clin Pharm Ther; 2004 Apr; 29(2):139-44. PubMed ID: 15068402
[TBL] [Abstract][Full Text] [Related]
12. Managing attention-deficit/hyperactivity disorder in primary care: a systematic analysis of roles and challenges.
Power TJ; Mautone JA; Manz PH; Frye L; Blum NJ
Pediatrics; 2008 Jan; 121(1):e65-72. PubMed ID: 18166546
[TBL] [Abstract][Full Text] [Related]
13. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].
Golubchik P; Sever J; Weizman A
Harefuah; 2011 Oct; 150(10):788-90, 814. PubMed ID: 22111124
[TBL] [Abstract][Full Text] [Related]
15. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
Bricard C; Boidein F
Encephale; 2001; 27(5):435-43. PubMed ID: 11760693
[TBL] [Abstract][Full Text] [Related]
16. Psychosocial treatments for preschool-aged children with Attention-Deficit Hyperactivity Disorder.
Laforett DR; Murray DW; Kollins SH
Dev Disabil Res Rev; 2008; 14(4):300-10. PubMed ID: 19072758
[TBL] [Abstract][Full Text] [Related]
17. Are stimulants overprescribed? Treatment of ADHD in four U.S. communities.
Jensen PS; Kettle L; Roper MT; Sloan MT; Dulcan MK; Hoven C; Bird HR; Bauermeister JJ; Payne JD
J Am Acad Child Adolesc Psychiatry; 1999 Jul; 38(7):797-804. PubMed ID: 10405496
[TBL] [Abstract][Full Text] [Related]
18. Splitting the self: the not-so-subtle consequences of medicating boys for ADHD.
White GB
Am J Bioeth; 2005; 5(3):57-9. PubMed ID: 16006364
[No Abstract] [Full Text] [Related]
19. [Update on Current Care guidelines: ADHD (attention-deficit/hyperactivity disorder, children and adolescents)].
Käypä hoito suosituksen päivitystiivistelmä
Duodecim; 2012; 128(5):539-40. PubMed ID: 22486070
[TBL] [Abstract][Full Text] [Related]
20. Clinical inquiries. Does increasing methylphenidate dose aid symptom control in ADHD?
Ibay AD; Bascelli LM; Graves RS; Hill J
J Fam Pract; 2003 May; 52(5):400, 403. PubMed ID: 12737774
[No Abstract] [Full Text] [Related]
[Next] [New Search]
